TWD
PTCT icon

True Wealth Design’s PTC Therapeutics PTCT Stock Holding History

True Wealth Design’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6K Hold
228
– – ﹤0.01% 835
2026
Q1 		$15.5K Sell
228
-1
-0.4% -$71 ﹤0.01% 815
2025
Q4 		$17.4K Hold
229
– – 0.01% 657
2025
Q3 		$14.1K Buy
229
+41
+22% +$2.14K ﹤0.01% 723
2025
Q2 		$9.18K Sell
188
-66
-26% -$3.13K ﹤0.01% 613
2025
Q1 		$12.9K Buy
254
+70
+38% +$3.49K ﹤0.01% 413
2024
Q4 		$8.31K Buy
184
+17
+10% +$728 ﹤0.01% 446
2024
Q3 		$6.2K Buy
+167
New +$5.59K ﹤0.01% 516

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

True Wealth Design's PTCT Position: Q2 2026 in Review

True Wealth Design held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 228 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #835.

True Wealth Design first reported a position in PTCT in Q3 2024 and has held it in 8 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • True Wealth Design held 228 shares of PTC Therapeutics worth $18.6K as of Q2 2026.
  • True Wealth Design left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #835 holding.
  • True Wealth Design first reported a position in PTC Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.